{"symbol":"BSX","fiscalQuarter":"Q1-2020","reportDate":"2020-04-29","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q1-2020","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 4.17%","keyNumbers":[{"metric":"EPS","actual":"$0.28","expected":"N/A","surprise":"-13.85%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management acknowledged the challenges posed by the current market conditions.","They emphasized their commitment to maintaining operational efficiency.","The team remains focused on long-term growth despite short-term hurdles."],"summary":"Management expressed cautious optimism about navigating current challenges. They highlighted their focus on operational efficiency and long-term growth."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a mixed picture, with a miss on EPS but a positive stock reaction, rising 4.17%. The stock's increase may reflect investor confidence in the company's long-term strategy despite the EPS miss. Management's focus on operational efficiency suggests they are preparing to tackle ongoing market challenges.","metaDescription":"Boston Scientific (BSX) Q1 2020 earnings: EPS missed expectations. Stock up 4.17%. Full breakdown."}}